Sign in
4

Changes in Ownership

Adaptive Biotechnologies Corp Filed Acc 0001209191-20-052780

SVP, Diagnostics, clonoSEQ sold 10,000 shares at $50.00 ($500,000)

  • SVP, Diagnostics, clonoSEQ acquired 10,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
BOBULSKY SUSAN SVP, Diagnostics, clonoSEQ 2020-09-29 Option exercise +10,000 $1.98 $19,800 10,000 D: show line 1 in the form
BOBULSKY SUSAN SVP, Diagnostics, clonoSEQ 2020-09-29 Sale −10,000 $50.00 $500,000 0 D: show line 2 in the form
Open-market sales · 10,000 sh · avg $50.00 · $500,000

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
BOBULSKY SUSAN SVP, Diagnostics, clonoSEQ 2020-09-29 Option exercise · Stock Option (Right to Buy) −10,000 55,000 D: show line 3 in the form
Loading xslF345X03/doc4.xml…